47
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

, , , &
Pages 275-281 | Published online: 31 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (3)